亚临床失眠中的情绪调节策略:对神经处理差异的电生理学见解
Siyu Li1,2, Zhuo Wang2, Yun Li3
1Lab of Light and Physio-Psychological Health, National Center for International Research on Green Optoelectronics, South China Normal University Guangzhou, China.
Journal of clinical and experimental neuropsychology
|December 16, 2025
概括
与对照人群相比,失眠症患者表现出改变了情绪调节策略和神经反应. 这些神经行为差异可能会导致失眠和情绪失调的持续.
科学领域:
- 神经科学是一个神经科学.
- 心理学 心理学 心理学
- 睡眠医学 睡眠医学
背景情况:
- 失眠障碍 (ID) 与情绪失调有关.
- 了解ID中情绪调节的神经行为基础至关重要.
研究的目的:
- 调查失眠障碍 (ID) 和正常对照 (NC) 个体之间的情绪调节策略中的神经行为差异.
- 通过电生理学 (EEG) 评估,探索失眠如何影响情绪调节策略.
主要方法:
- 招募了25名患有亚临床失眠障碍症状的人 (ID组) 和22名正常对照人 (NC组).
- 参与者在使用中立视图 (NV) 和受控重新评估 (CR) 策略执行情绪调节任务时进行了EEG记录.
- 收集并比较行为反应,前额α不对称性,事件相关潜能 (ERP) 和频率域EEG分析.
主要成果:
- ID组在使用NV策略时表现出更长的响应时间,并报告了更低的兴奋水平.
- 在电生理学上,ID组显示在负图像中CR期间前额α不对称性下降,ERP组件 (N2,P2,LPP,P3) 发生变化,theta功率更大,后部α功率增强.
- 阿尔法振荡与NC中的行为相关,但与ID无关,表明失眠时大脑行为合发生变化.
结论:
- 失眠患者对上下情绪调节的行为和神经反应有着不同的表现.
- 不眠症中神经反应模式的改变可能会导致睡眠障碍和相关情绪失调的持续.
相关概念视频
Management of Insomnia
499
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
499
Sedatives and Hypnotics Drugs: Miscellaneous Agents
477
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
477
Sedatives and Hypnotics: Overview
1.3K
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
1.3K
Insomnia
380
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
380


